Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: PFE

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair
Today, 2:52 AM
Major Wall Street indices had closed in the red on Friday in the wake of a continued sell-off following the hawkish stance asserted by the Federal Reserve. Friday witnessed volatile trading as a large number of o

AMZN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Long Ideas
  • Markets
  • News
  • Small Cap
  • Trading Ideas

Jim Cramer Recommends These 5 Healthcare Stocks For 2023: ‘Biggest Winners Were Boring, Consistent Operators’

By Bhavik Nair
Today, 2:52 AM
Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023.

BHVN

Read More
1 minute read
  • Government
  • Regulations

Senators Warren And Welch Press Pfizer On Plans To Raise COVID-19 Vaccine Prices

By Benzinga Newsdesk
Today, 2:52 AM
https://thehill.com/policy/healthcare/3773665-warren-welch-press-pfizer-ceo-on-covid-vaccine-price-hike/

PFE

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
Today, 2:52 AM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

BSX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Analyst Bullish On Theseus Pharma’s Platform For Gastric Cancer Therapies

By Vandana Singh
Today, 2:52 AM
Needham has initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating and a price target of $22. Theseus’ discovery platform…

DCPH

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Comparing With Pfizer’s Vaccine, Icosavax RSV Candidate ‘Could Establish Differentiation,’ Analyst Says

By Vandana Singh
Today, 2:52 AM
Icosavax Inc (NASDAQ:ICVX) provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against Respiratory Syncytial Virus (RSV), demonstrating…

GSK

Read More
4 minute read
  • Biotech
  • General
  • News

Pfizer Announces U.S. Collaboration With Roche To Help Patients Who Test Positive For Covid-19 Navigate Risks, Symptoms, Testing And Treatment Options

By Benzinga Newsdesk
Today, 2:52 AM
Testing early for COVID-19 can help determine the proper course of treatment. This collaboration helps patients access critical resources and locate information about testing, available treatment options,

PFE

Read More
1 minute read
  • Contracts
  • News

U.S. Defense Department Says Pfizer Awarded $1.96B Modification To Contract For Oral COVID-19 Therapeutic Paxlovid

By Michael Horton
Today, 2:52 AM
-Reuters

PFE

Read More
1 minute read
  • Biotech
  • General

Pfizer Says Actively Collaborating With All Stakeholders To Secure An Adequate Supply Of Covid Drug Paxlovid In China

By Bill Haddad
Today, 2:52 AM
-Reuters

PFE

Read More
2 minute read
  • Biotech
  • General
  • Legal
  • News

‘Florida Gov. DeSantis Calls For Grand Jury To Investigate Covid Vaccines’ – InsiderPaper

By Benzinga Newsdesk
Today, 2:52 AM
https://insiderpaper.com/florida-gov-desantis-calls-for-grand-jury-to-investigate-covid-vaccines/ Ron DeSantis, the Governor of Florida, announced his decision to appoint a grand jury to investigate the

AZN

Posts navigation

Previous 1 … 11 12 13 … 160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service